Artefenomel Mesylate

The recent withdrawal of artefenomel from clinical development leaves no endoperoxide-class agents in the antimalarial pipeline. Synthetic endoperoxides with a desymmetrized structure have demonstrated promising physiochemical and in vivo properties. Here we expand on our initial investigation of trans-3″ carbamate substitution with a diverse array of amine-, alcohol-, and sulfinyl-terminated analogues prepared in (S,S) and (R,R) configurations. In general, this chemotype combines low-nM antiplasmodial activity with excellent aqueous solubility but widely varying human liver microsome (HLM) stability. We evaluated 20 novel analogues in the P. berghei mouse malaria model, identifying new analogues such as RLA-4767 (9a) and RLA-5489 (9d), with HLM stability and pharmacokinetic profiles superior to analogues from our initial report (e.g., RLA-4776, 8a). These new leads approach or equal the efficacy of artefenomel after two daily oral doses of 10 mg/kg, thus revealing a promising chemotype with the potential to deliver development candidates.

A review.Fragment-based drug design of new bioactive scaffolds is a recent aspect of medicinal chem. that provides a faster and more efficient road in drug discovery.Phenoxyethyl piperidine and morpholine derivatives have various pharmacol. activities, from antitussive to anticancer properties.They are also widely used in selective estrogen receptor modulator (SERM) drugs and can be used to prevent osteoporosis in postmenopausal women.Also, other recent findings suggest that these compounds exhibit high anticholinergic and H3 inverse agonistic activities.We outlined the process of developing novel medications for Alzheimer′s disease, malaria, cancer, and various other illnesses, which could entail modifying or incorporating these structures into a different biol. active framework.Pharmacokinetic assessment and organic pathways for synthesizing these scaffolds are also indicated.This review will discuss the recent pharmaceutical advances of phenoxyethyl cyclic amine derivatives in exptl., investigational, and FDA-approved drugs to draw an apparent viewpoint for future drug research and discovery.